NOVAN INC

NASDAQ

NOVN

$NOVN has a multiple tops above $3, particularly $3.02 and the 52-week high of $3.24 a share. $NOVN has been a runner in the past and we could get momentum players in the stock on new highs. Novan, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and...

Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in...

$NOVN is in a bull flag and on the verge of a breakout. The way to trade is to go long $NOVN above $3. A move above $3 will test the 52-week highs of $3.24. A move above $3.24 and we will look to close the gap to $4.19. Risk is minimal as a move above $3 should work out right away. If $NOVN closes the gap, upside is 40%. Not a bad risk/reward play is it? As...

************************A CAVALCADE OF GOOD NEWS LATELY IN NASDAQ:NOVN HAS SPURNED A EPIC RALLY FROM LATE APRIL. NOT TO WORRY IF YOU HAVE NOT BEEN INVOLVED THERE IS PLENTY OF ACTION LEFT IN THIS NAME AS INSIDERS HAVE BEEN BUYING UP SHARES. A BREAK ABOVE $2.45 IS A GOOD BUY SIGNAL ON GOOD VOLUME ********************* On May 6, it announced that it sold the...

Bouncing in a channel news earnings may provide some change in my pocket

novan has fda approval for phase iii trials watching for breakup

+75% here so far...

Ive seen plenty of young pharmaceutical companies with little to no fundamental value take off early on. Nolan is in a third phase trial and has bullish sentiment. I think if it breaks its all time closing price high of 22.54, a strong move to 25-30 is possible.